ENGEN BIO

engen-bio-logo

EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza. It believes that it has identified a candidate Universal Type A Influenza vaccine. Influenza drugs and vaccines are unique because there is sufficient government funding available to develop these assets well into human clinical trials, and possibly to market. EnGen Bio is aggressively pursuing this and similar opportunities. It is founded in 2017 and is headquartered in Redwood City, California.

#SimilarOrganizations #People #Financial #Website #More

ENGEN BIO

Industry:
Biotechnology Health Care Health Diagnostics Life Science

Founded:
2016-01-01

Address:
Redwood City, California, United States

Country:
United States

Website Url:
http://www.engenbio.com

Total Employee:
11+

Status:
Active

Total Funding:
812 K USD


Similar Organizations

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

Current Employees Featured

mark-alfenito_image

Mark Alfenito
Mark Alfenito Co-Founder, President, Manager & Chief Executive Officer @ EnGen Bio
Co-Founder, President, Manager & Chief Executive Officer

geoffrey-yarranton_image

Geoffrey Yarranton
Geoffrey Yarranton Science Advisor @ EnGen Bio
Science Advisor
2015-11-01

Founder


mark-alfenito_image

Mark Alfenito

Investors List

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - EnGen Bio

Official Site Inspections

http://www.engenbio.com

  • Host name: 104.237.12.198.host.secureserver.net
  • IP address: 198.12.237.104
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "EnGen Bio"

Home - EnGen Bio

Unlike conventional flu vaccines, which are generally hemagglutinin or whole-virus based, our vaccine targets a region, a novel epitope on the flu virusโ€™s M1 matrix protein, to elicit โ€ฆSee details»

EnGen Bio - Crunchbase Company Profile & Funding

EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza. It believes that it has identified โ€ฆSee details»

ENGEN BIO - LinkedIn

EnGen is an early-stage biotechnology company pioneering a new approach to preventing and treating influenza. We're developing an effective, easy-to-manufacture, shelf-stable universal flu vaccine ...See details»

EnGen Bio 2025 Company Profile: Valuation, Funding

EnGen Bio General Information Description. Operator of a biotechnology company intended to develop therapy and vaccines to provide lifetime โ€ฆSee details»

EnGen Bio: A Vaccine and Therapy to Provide ... - EnGen Bio on โ€ฆ

See details»

EnGen Bio, LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for EnGen Bio, LLC of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»

EnGen Bio - Products, Competitors, Financials, Employees, โ€ฆ

Engenbio.com. Overview & Products; Financials; People; Founded Year 2016. Stage Unattributed | Alive. Total Raised $630K. Last Raised $630K | 5 yrs ago. Mosaic Score. The Mosaic Score โ€ฆSee details»

ENGEN BIO Overview | SignalHire Company Profile

Organization Website: engenbio.com : ENGEN BIO industries Pharma: Headquarters Location: 61 AVONDALE AVE., REDWOOD CITY, California, 94062 US 61 AVONDALE AVE., โ€ฆSee details»

ENGEN BIO - Org Chart, Teams, Culture & Jobs - The Org

View ENGEN BIO's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Engen Bio LLC: Drug pipelines, Patents, Clinical trials - Synapse

Explore Engen Bio LLC with its drug pipeline, therapeutic area, technology platform, 2 news.See details»

Our Team - EnGen Bio

EnGen Bioโ€™s expert researchers hold more than 50 patents in therapeutic treatment of seasonal flu and development of universal vaccine for Type A influenza.See details»

ENGEN BIO - Company Profile & Staff Directory - ContactOut

EnGen is an early-stage biotechnology company pioneering a new approach to preventing and treating influenza. We're developing an effective, easy-to-manufacture, shelf-stable universal โ€ฆSee details»

EnGen Bio - Overview, News & Similar companies | ZoomInfo.com

Mar 31, 2021 View EnGen Bio (www.engenbio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Universal flu vaccine pioneer EnGen Bio announces a registered โ€ฆ

San Francisco, CA โ€“ March 31, 2021 EnGen Bio is an early stage biotechnology company developing a new approach to preventing and treating all Type A influenza strainsโ€”including โ€ฆSee details»

Engen Bio - Company Info, Employees & Competitors

View Engen bio engenbio.com location in 61 avondale ave, redwood city, california, 94062, united states, revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

EnGen Bio announces a registered equity crowdfunding campaign, โ€ฆ

Feb 25, 2021 Seasonal flu causes 50,000โ€“250,000 deaths worldwide annually, causing the World Health Organization to declare the development of a universal flu vaccine as an urgent โ€ฆSee details»

Universal flu vaccine pioneer EnGen Bio announces a registered โ€ฆ

Mar 31, 2021 Seasonal flu causes 50,000โ€“250,000 deaths worldwide annually, causing the World Health Organization to declare the development of a universal flu vaccine as an urgent โ€ฆSee details»

Universal flu vaccine pioneer EnGen Bio announces a ... - BioSpace

SAN FRANCISCO, March 31, 2021 /PRNewswire/ -- EnGen Bio is an early stage biotechnology company developing a new approach to preventing and treating all Type A influenza โ€ฆSee details»

News - EnGen Bio

Seasonal flu causes 50,000-250,000 deaths worldwide annually โ€“ causing the World Health Organization (WHO) to declare the development of a universal flu vaccine as an urgent need โ€ฆSee details»

Our Science - EnGen Bio

Based on this exciting discovery, we hypothesized that the M1 exposed region could serve as the basis for a completely new type of universal therapy and a universal vaccine against all Type โ€ฆSee details»

linkstock.net © 2022. All rights reserved